Search Results - "Nishiyama, Daichi"

Toward further simplification of elotuzumab therapy by subcutaneous administration by Shimura, Yuji, Tsukamoto, Taku, Yamaguchi, Junko, Kuwahara-Ota, Saeko, Isa, Reiko, Nishiyama, Daichi, Kobayashi, Tsutomu, Horiike, Shigeo, Suzuki, Atsushi, Kuroda, Junya

Get full text

EWSR1 overexpression is a pro-oncogenic event in multiple myeloma by Nishiyama, Daichi, Chinen, Yoshiaki, Isa, Reiko, Fujibayashi, Yuto, Kuwahara-Ota, Saeko, Yamaguchi, Junko, Takimoto-Shimomura, Tomoko, Matsumura-Kimoto, Yayoi, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Handa, Hiroshi, Kuroda, Junya

“…Multiple myeloma (MM) is cytogenetically, genetically and molecularly heterogenous even among subclones in one patient, therefore, it is essential to identify…”
Get full text

Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia by Yamaguchi, Junko, Fujino, Takahiro, Isa, Reiko, Nishiyama, Daichi, Kuwahara-Ota, Saeko, Kawaji, Yuka, Tsukamoto, Taku, Chinen, Yoshiaki, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Kohno, Kei, Nakamura, Shigeo, Kuroda, Junya

Get full text

Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma by Fujibayashi, Yuto, Isa, Reiko, Nishiyama, Daichi, Sakamoto-Inada, Natsumi, Kawasumi, Norichika, Yamaguchi, Junko, Kuwahara-Ota, Saeko, Matsumura-Kimoto, Yayoi, Tsukamoto, Taku, Chinen, Yoshiaki, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Handa, Hiroshi, Kuroda, Junya

“…Chromosome instability (CIN), the hallmarks of cancer, reflects ongoing chromosomal changes caused by chromosome segregation errors and results in whole…”
Get full text

A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma by Mizuno, Yoshimi, Chinen, Yoshiaki, Tsukamoto, Taku, Takimoto-Shimomura, Tomoko, Matsumura-Kimoto, Yayoi, Fujibayashi, Yuto, Kuwahara-Ota, Saeko, Fujino, Takahiro, Nishiyama, Daichi, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

“…Chromosomal microdeletions frequently cause loss of prognostically relevant tumor suppressor genes in hematologic malignancies; however, detection of minute…”
Get full text

Effects of Establishing a Department of General Internal Medicine on the Length of Hospitalization by Wada, Mikio, Nishiyama, Daichi, Kawashima, Atsushi, Fujiwara, Misaki, Kagawa, Keizo

“…Objective This study aimed to evaluate the effects of establishing a Department of General Internal Medicine (DGIM) on the length of hospitalization. We…”
Get full text

Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma by Matsumura‐Kimoto, Yayoi, Tsukamoto, Taku, Shimura, Yuji, Chinen, Yoshiaki, Tanba, Kazuna, Kuwahara‐Ota, Saeko, Fujibayashi, Yuto, Nishiyama, Daichi, Isa, Reiko, Yamaguchi, Junko, Kawaji‐Kanayama, Yuka, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

“…RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL),…”
Get full text

Neurolymphomatosis of cranial nerves as the responsible lesions for the vocal cord paralysis and facial nerve palsy in a patient with diffuse large B-cell lymphoma by Inoue, Yu, Hirakawa, Koichi, Hayata, Hiroki, Nishiyama, Daichi, Fujino, Takahiro, Tsukamoto, Taku, Mizutani, Shinsuke, Shimura, Yuji, Kuroda, Junya

Get full text

Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma by Kuwahara‐Ota, Saeko, Shimura, Yuji, Steinebach, Christian, Isa, Reiko, Yamaguchi, Junko, Nishiyama, Daichi, Fujibayashi, Yuto, Takimoto‐Shimomura, Tomoko, Mizuno, Yoshimi, Matsumura‐Kimoto, Yayoi, Tsukamoto, Taku, Chinen, Yoshiaki, Kobayashi, Tsutomu, Horiike, Shigeo, Taniwaki, Masafumi, Gütschow, Michael, Kuroda, Junya

“…Summary An increase in immunosuppressive myeloid‐derived suppressor cells (MDSCs) is associated with disease progression and treatment resistance in multiple…”
Get full text

Nutritional and Cytogenetic Assessment Predicts Favorable Response to Azacitidine Monotherapy for Myelodysplastic Syndromes by Okamoto, Haruya, Inoue, Yu, Miyashita, Akihiro, Kawaji-Kanayama, Yuka, Chinen, Shotaro, Fujino, Takahiro, Tsukamoto, Taku, Shimura, Yuji, Mizutani, Shinsuke, Kaneko, Hiroto, Kuwahara, Saeko, Fuchida, Shin-ichi, Nishiyama, Daichi, Hirakawa, Koichi, Kuroda, Junya

Get full text

Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma by Onishi, Akio, Matsumura-Kimoto, Yayoi, Mizutani, Shinsuke, Isa, Reiko, Fujino, Takahiro, Tsukamoto, Taku, Miyashita, Akihiro, Okumura, Keita, Nishiyama, Daichi, Hirakawa, Koichi, Shimura, Kazuho, Kaneko, Hiroto, Kiyota, Miki, Kawata, Eri, Takahashi, Ryoichi, Kobayashi, Tsutomu, Uchiyama, Hitoji, Uoshima, Nobuhiko, Nukui, Yoko, Shimura, Yuji, Inaba, Tohru, Kuroda, Junya

“…Multiple myeloma reduces cellular and humoral immunity. Optimal prediction of antibody response to anti-severe acute respiratory syndrome coronavirus 2…”
Get full text

Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system by Okamoto, Haruya, Inoue, Yu, Miyashita, Akihiro, Kawaji-Kanayama, Yuka, Chinen, Shotaro, Fujino, Takahiro, Tsukamoto, Taku, Shimura, Yuji, Mizutani, Shinsuke, Kaneko, Hiroto, Kuwahara-Ota, Saeko, Fuchida, Shin-ichi, Nishiyama, Daichi, Hirakawa, Koichi, Uchiyama, Hitoji, Uoshima, Nobuhiko, Kawata, Eri, Kuroda, Junya

“…The prognostic impact of patient-related factors, including age, nutritional parameters, and inflammation status, in higher-risk myelodysplastic syndromes…”
Get full text

Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System by Inoue, Yu, Okamoto, Haruya, Miyashita, Akihiro, Kawaji-Kanayama, Yuka, Chinen, Shotaro, Fujino, Takahiro, Tsukamoto, Taku, Shimura, Yuji, Mizutani, Shinsuke, Kaneko, Hiroto, Kuwahara-Ota, Saeko, Fuchida, Shin-Ichi, Nishiyama, Daichi, Hirakawa, Koichi, Uchiyama, Hitoji, Uoshima, Nobuhiko, Kawata, Eri, Kuroda, Junya

“…Azacitidine (AZA) has been one of the standard treatments for transplantation-ineligible patients with myelodysplastic syndrome (MDS); however, hematological…”
Get full text

Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti-SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms by Onishi, Akio, Matsumura-Kimoto, Yayoi, Mizutani, Shinsuke, Tsukamoto, Taku, Fujino, Takahiro, Miyashita, Akihiro, Nishiyama, Daichi, Shimura, Kazuho, Kaneko, Hiroto, Kawata, Eri, Takahashi, Ryoichi, Kobayashi, Tsutomu, Uchiyama, Hitoji, Uoshima, Nobuhiko, Nukui, Yoko, Shimura, Yuji, Inaba, Tohru, Kuroda, Junya

“…Anti-CD20 monoclonal antibodies (MoAbs), rituximab (RIT), and obinutuzumab (OBZ) are the central components of immunochemotherapy for B-cell lymphoma (BCL)…”
Get full text

Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma by Yamaguchi, Junko, Chinen, Yoshiaki, Takimoto-Shimomura, Tomoko, Nagata, Hiroaki, Muramatsu, Ayako, Kuriyama, Kodai, Ohshiro, Muneo, Hirakawa, Yoshiko, Iwai, Toshiki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Kaneko, Hiroto, Nakao, Mitsushige, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Yokota, Isao, Kuroda, Junya

“…Delayed platelet engraftment (DPE) is occasionally observed despite prompt neutrophil engraftment after autologous peripheral blood stem cell transplantation…”
Get full text